Savara Pharmaceuticals
SVRA
$3.93
Share price
1.55%
Change (1 day)
28.01%
Change (1 year)
Categories
Savara Pharmaceuticals (SVRA) - Cash on Hand
Cash on Hand as of March 2024 : $0.14 B
According to Savara Pharmaceuticals's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Savara Pharmaceuticals - Cash on Hand chart (from 2002 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 28.95% |
| 2022-12-31 | $0.12 B | -21.9% |
| 2021-12-31 | $0.16 B | 96.1% |
| 2020-12-31 | $82.18 M | -32.5% |
| 2019-12-31 | $0.12 B | 9.86% |
| 2018-12-31 | $0.11 B | 17.51% |
| 2017-12-31 | $94.31 M | 605.25% |
| 2016-12-31 | $13.37 M | -67.37% |
| 2015-12-31 | $40.98 M | -28.47% |
| 2014-12-31 | $57.28 M | 29.05% |
| 2013-12-31 | $44.39 M | 21.58% |
| 2012-12-31 | $36.51 M | -27.99% |
| 2011-12-31 | $50.7 M | 81.22% |
| 2010-12-31 | $27.97 M | 222.81% |
| 2009-12-31 | $8.66 M | -12.01% |
| 2008-12-31 | $9.84 M | -70.56% |
| 2007-12-31 | $33.46 M | -35.33% |
| 2006-12-31 | $51.74 M | 129.03% |
| 2005-12-31 | $22.59 M | 73.36% |
| 2004-12-31 | $13.03 M | 208.35% |
| 2003-12-31 | $4.22 M | 3966.66% |
| 2002-12-31 | $0.1 M | -36.81% |
| 2001-12-31 | $0.16 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $75.63 M | -47.12% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $16.39 M | -88.54% | 🇺🇸 USA |